Heparin sodium biosimilar (Blau Pharmaceuticals)

肝素钠生物类似药 (Blau Pharmaceuticals)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHeparin sodium biosimilar (Blau Pharmaceuticals)
Drug Alias Name肝素钠生物仿制药 (Blau Pharmaceuticals)Hepamax-S
ClassificationNatural product/Extract > Animal extractBiologics > Biosimilar
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsThrombosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryBrazil
Original Approved Date2012/08/01
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBlau Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesBlau Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeB01AB01C05BA03S01XA14
Related LinksN/A